In KFF’s 2026 survey, 18% of employers with at least 200 workers that offered health benefits said their largest plan covered a GLP-1 for weight loss. Coverage differed by firm size: 16% vs. 33% for firms with 200 to 999 workers and firms with at least 5,000 workers, respectively. Among firms with 1,000 to 4,999 workers, 29% reported coverage[9]. If your plan excludes it, compare the full monthly cost of a GLP-1 before budgeting for treatment.
What the employer survey counts
KFF reported 19% in 2025[1]. Both years describe the largest plan at firms with at least 200 workers that offered benefits. The question was about weight-loss use. Check the formulary for the reason your clinician prescribed the drug.
Two people prescribed the same drug at the same dose can pay different amounts because coverage depends on the diagnosis and the plan’s rules. The GLP-1 insurance guide explains what to compare when you have both a plan estimate and a cash quote. Check whether either amount excludes care or pharmacy charges.
What employer coverage can still cost
In KFF’s 2026 survey, family premiums averaged $28,303 a year. Covered workers contributed an average of $7,471 a year toward family coverage. Among workers with single coverage and a general annual deductible, that deductible averaged $1,955[9]. Ask your plan for the prescription’s cost separately, since the premium and general deductible alone do not tell you what you would pay at the pharmacy.
Who the tirzepatide survey measured
A survey of 518 full-time employed US adults who were starting tirzepatide found that 80.9% had employer-provided insurance. Among those with employer insurance, 55.9% reported coverage for obesity medication[2]. KFF surveyed employers. This study surveyed employees who had accessed treatment.
The survey did not include people who never started treatment. For a different view of access, see our analysis of the people offered a prescription who declined it.
What an employer is actually weighing
Our summary of a survey of Swedish physicians describes access barriers from a different health system. These employer figures describe U.S. benefit decisions.
Among the 518 surveyed employees who were starting tirzepatide, 52.3% said they would consider changing jobs to obtain coverage for obesity medication. Another 81.7% said that coverage could increase job satisfaction[2]. The survey measured what those employees said they might do. It did not track whether they changed jobs.
The survey also measured self-reported work and activity impairment at baseline. It did not measure a change in impairment after treatment began.
Wegovy fills rose after coverage expanded
In March 2024 the FDA expanded Wegovy’s indication for adults with established cardiovascular disease and overweight or obesity[10]. Medicare Part D began covering it for that indication. The Wegovy coverage analysis explains how the researchers counted Part D fills and describes the later Medicare demonstration. National prescription data show Wegovy fills increased 136.4% across payers. Part D fills rose from 4,689 in February to 32,732 in September 2024[3]. The authors’ regression associated the policy changes with an estimated 592,624 additional fills by September 2024.
The Medicare coverage guide explains how the condition being treated affects coverage. Check your own plan for the approved uses, eligibility requirements and out-of-pocket costs.
What to ask, and who decides
Ask human resources or the plan for its current formulary and coverage criteria. Give them the product and the condition your clinician is treating. Ask whether the benefit uses a separate program and who can prescribe under it.
When your plan uses 9amHealth
The insurance coverage worksheet gives you a place to record the program, prescribing and pharmacy rules your plan confirms. For example, 9amHealth’s SmithRx page describes an employer option that requires its own prescriber for covered weight-management GLP-1s[4]. Ask whether that rule applies to your benefit.
9amHealth offers a program through employers[5]. Its direct sign-up page currently takes waitlist requests[6]. If your employer lists 9amHealth as a benefit, ask which enrollment link to use and what you would pay for the visit and the prescription.
Check who can write a covered prescription. The EncircleRx page describes a choice between your existing clinician and a 9amHealth clinician for that program[7]. The 9amHealth member guide lists Wegovy and Zepbound among the medications its care team may prescribe for eligible members. Ask which drug and pharmacy your plan covers. Also ask about the medication copay. The Amazon program, for example, offers care at no charge to eligible members but says medication cost-sharing may apply[8].
If the drug is covered but approval is pending, the prior authorization timeline explains when to check whether the plan received the request. Ask your benefits team who can confirm the status.